Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. Johnson JR, et al. J Pain Symptom Manage. 2013 Aug;46(2):207-18. doi: 10.1016/j.jpainsymman.2012.07.014. Epub 2012 Nov 8. J Pain Symptom Manage. 2013. PMID: 23141881 Clinical Trial.
Repurposing Medications for Hospice/Palliative Care Symptom Control Is No Longer Sufficient: A Manifesto for Change.
Currow DC, Abernethy AP, Fallon M, Portenoy RK. Currow DC, et al. J Pain Symptom Manage. 2017 Mar;53(3):533-539. doi: 10.1016/j.jpainsymman.2016.10.358. Epub 2016 Dec 30. J Pain Symptom Manage. 2017. PMID: 28042066
Pain related to cancer treatments and diagnostic procedures: a no man's land?
Ripamonti CI, Bossi P, Santini D, Fallon M. Ripamonti CI, et al. Ann Oncol. 2014 Jun;25(6):1097-106. doi: 10.1093/annonc/mdu011. Epub 2014 Mar 13. Ann Oncol. 2014. PMID: 24625453 Review.
Quantitative Sensory Testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response.
Scott AC, McConnell S, Laird B, Colvin L, Fallon M. Scott AC, et al. Eur J Pain. 2012 Jan;16(1):123-33. doi: 10.1016/j.ejpain.2011.05.002. Eur J Pain. 2012. PMID: 21658980
Transdermal fentanyl in cancer pain: conversion from oral morphine.
Hanks GW, Fallon MT. Hanks GW, et al. J Pain Symptom Manage. 1995 Feb;10(2):87. doi: 10.1016/s0885-3924(08)80004-8. J Pain Symptom Manage. 1995. PMID: 7537319 No abstract available.
Symptomatic hypocalcemia with oral clodronate.
Johnson MJ, Fallon MT. Johnson MJ, et al. J Pain Symptom Manage. 1998 Feb;15(2):140-2. doi: 10.1016/s0885-3924(98)80015-8. J Pain Symptom Manage. 1998. PMID: 9494315
Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study.
Fallon M, Reale C, Davies A, Lux AE, Kumar K, Stachowiak A, Galvez R; Fentanyl Nasal Spray Study 044 Investigators Group. Fallon M, et al. J Support Oncol. 2011 Nov-Dec;9(6):224-31. doi: 10.1016/j.suponc.2011.07.004. J Support Oncol. 2011. PMID: 22055892 Clinical Trial.
Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain.
Davies A, Sitte T, Elsner F, Reale C, Espinosa J, Brooks D, Fallon M. Davies A, et al. J Pain Symptom Manage. 2011 Feb;41(2):358-66. doi: 10.1016/j.jpainsymman.2010.11.004. J Pain Symptom Manage. 2011. PMID: 21334555 Clinical Trial.
Ibandronate: its role in metastatic breast cancer.
Cameron D, Fallon M, Diel I. Cameron D, et al. Oncologist. 2006;11 Suppl 1:27-33. doi: 10.1634/theoncologist.11-90001-27. Oncologist. 2006. PMID: 16971737 Review.
Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer.
Sheridan D, Foo I, O'Shea H, Gillanders D, Williams L, Fallon M, Colvin L. Sheridan D, et al. J Pain Symptom Manage. 2012 Oct;44(4):608-14. doi: 10.1016/j.jpainsymman.2011.10.021. Epub 2012 Jun 27. J Pain Symptom Manage. 2012. PMID: 22743155
75 results
Jump to page